Cargando…
Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients
BACKGROUND: Minimally invasive vertebral augmentation procedures are widely used to treat vertebral compression fractures although procedural polymethylmethacrylate cement leakage remains common. We report herein our initial experience with a novel vertebral augmentation technique designed to treat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189204/ https://www.ncbi.nlm.nih.gov/pubmed/21939548 http://dx.doi.org/10.1186/1471-2474-12-206 |
_version_ | 1782213448503918592 |
---|---|
author | Korovessis, Panagiotis Repantis, Thomas Miller, Larry E Block, Jon E |
author_facet | Korovessis, Panagiotis Repantis, Thomas Miller, Larry E Block, Jon E |
author_sort | Korovessis, Panagiotis |
collection | PubMed |
description | BACKGROUND: Minimally invasive vertebral augmentation procedures are widely used to treat vertebral compression fractures although procedural polymethylmethacrylate cement leakage remains common. We report herein our initial experience with a novel vertebral augmentation technique designed to treat symptomatic vertebral osteoporotic fractures and osteolytic metastases with minimal cement extravasation. METHODS: Forty-two vertebral fractures were identified in 26 consecutive patients (mean age 74 ± 9 years). All patients were treated with a novel percutaneous vertebral augmentation device (Kiva(® )VCF Treatment System, Benvenue Medical, Santa Clara, CA, USA). Indications for surgery included recent (≤ 3 months) symptomatic osteoporotic vertebral fracture (n = 34) and pathologic vertebral fractures (e.g. metabolic bone disease, myeloma, metastasis) (n = 8) located between T10 and S1. Patient outcomes were evaluated pre-treatment and at 2- and 6-month follow-up visits. Postoperative cement extravasation was assessed with computed tomography. Patient-reported back pain was quantified using an 11-point numeric scale. Back-specific functional disability was self-reported with the Oswestry Disability Index on a 0 to 100% scale. RESULTS: No cases of intraoperative hypotension, respiratory disturbance, neurological deterioration, infection, or death were observed. There were 2 (4.8%) levels where anterior cement leakage was visible radiographically in patients with osteolyses. No intracanal leakage was observed. Back pain scores improved 71% (p < 0.001) from pre-treatment to the 6-month follow-up. Back function improved 56% from baseline to 6 months (p < 0.001). CONCLUSIONS: The initial clinical experience with the Kiva(® )System demonstrated significant improvements in back pain and function with minimal and clinically insignificant procedural cement leakage. |
format | Online Article Text |
id | pubmed-3189204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31892042011-10-08 Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients Korovessis, Panagiotis Repantis, Thomas Miller, Larry E Block, Jon E BMC Musculoskelet Disord Research Article BACKGROUND: Minimally invasive vertebral augmentation procedures are widely used to treat vertebral compression fractures although procedural polymethylmethacrylate cement leakage remains common. We report herein our initial experience with a novel vertebral augmentation technique designed to treat symptomatic vertebral osteoporotic fractures and osteolytic metastases with minimal cement extravasation. METHODS: Forty-two vertebral fractures were identified in 26 consecutive patients (mean age 74 ± 9 years). All patients were treated with a novel percutaneous vertebral augmentation device (Kiva(® )VCF Treatment System, Benvenue Medical, Santa Clara, CA, USA). Indications for surgery included recent (≤ 3 months) symptomatic osteoporotic vertebral fracture (n = 34) and pathologic vertebral fractures (e.g. metabolic bone disease, myeloma, metastasis) (n = 8) located between T10 and S1. Patient outcomes were evaluated pre-treatment and at 2- and 6-month follow-up visits. Postoperative cement extravasation was assessed with computed tomography. Patient-reported back pain was quantified using an 11-point numeric scale. Back-specific functional disability was self-reported with the Oswestry Disability Index on a 0 to 100% scale. RESULTS: No cases of intraoperative hypotension, respiratory disturbance, neurological deterioration, infection, or death were observed. There were 2 (4.8%) levels where anterior cement leakage was visible radiographically in patients with osteolyses. No intracanal leakage was observed. Back pain scores improved 71% (p < 0.001) from pre-treatment to the 6-month follow-up. Back function improved 56% from baseline to 6 months (p < 0.001). CONCLUSIONS: The initial clinical experience with the Kiva(® )System demonstrated significant improvements in back pain and function with minimal and clinically insignificant procedural cement leakage. BioMed Central 2011-09-22 /pmc/articles/PMC3189204/ /pubmed/21939548 http://dx.doi.org/10.1186/1471-2474-12-206 Text en Copyright ©2011 Korovessis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Korovessis, Panagiotis Repantis, Thomas Miller, Larry E Block, Jon E Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients |
title | Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients |
title_full | Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients |
title_fullStr | Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients |
title_full_unstemmed | Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients |
title_short | Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients |
title_sort | initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: a case series of 26 consecutive patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189204/ https://www.ncbi.nlm.nih.gov/pubmed/21939548 http://dx.doi.org/10.1186/1471-2474-12-206 |
work_keys_str_mv | AT korovessispanagiotis initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients AT repantisthomas initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients AT millerlarrye initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients AT blockjone initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients |